 | • レポートコード：20QY06-05749 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、細菌性膣炎薬のグローバル市場について種類別（Rx、OTC）、用途別（病院、薬局、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・細菌性膣炎薬市場の概要 ・世界の主要地域別細菌性膣炎薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の細菌性膣炎薬市場規模2015-2026：種類別（Rx、OTC） ・世界の細菌性膣炎薬市場規模2015-2026：用途別（病院、薬局、その他） ・細菌性膣炎薬の北米市場規模2015-2020 ・細菌性膣炎薬のヨーロッパ市場規模2015-2020 ・細菌性膣炎薬の中国市場規模2015-2020 ・細菌性膣炎薬の日本市場規模2015-2020 ・細菌性膣炎薬の東南アジア市場規模2015-2020 ・細菌性膣炎薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bayer、、Pfizer、、Sanofi、、Piramal、、Abbott、、Galderma、、Mission、、Alkem、、Xiuzheng、、Teva、、Perrigo、、West-Ward、、HPGC、、Yunnan Baiyao、、Starpharma、、Novel、、Edenvridge、） ・細菌性膣炎薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・細菌性膣炎薬の市場動向・機会・課題 ・調査の結論 |
Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria.
The classification of bacterial vaginosis drug includes Rx and OTC, and the proportion of OTC in 2016 is about 72%.
Bacterial vaginosis drug is widely sold in hospital, pharmacy and other field. The most proportion of bacterial vaginosis drug is sold in pharmacy, and the revenue in 2016 is about 423 M USD.
USA region is the largest supplier of bacterial vaginosis drug, with a revenue market share nearly 32% in 2016. Europe is the second largest supplier of Bacterial Vaginosis Drug, enjoying revenue market share nearly 30% in 2016.
USA and Europe are the largest consumption places, with the consumption market share nearly 28% in 2016.
Market competition is intense. Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Bacterial Vaginosis Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Bacterial Vaginosis Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Bacterial Vaginosis Drug industry.
Based on our recent survey, we have several different scenarios about the Bacterial Vaginosis Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 858.4 million in 2019. The market size of Bacterial Vaginosis Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Bacterial Vaginosis Drug Scope and Market Size
The global Bacterial Vaginosis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Vaginosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bacterial Vaginosis Drug market is segmented into
Rx
OTC
Segment by Application, the Bacterial Vaginosis Drug market is segmented into
Hospital
Pharmacy
Other
The Bacterial Vaginosis Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Bacterial Vaginosis Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bacterial Vaginosis Drug Market Share Analysis
Bacterial Vaginosis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bacterial Vaginosis Drug business, the date to enter into the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug product introduction, recent developments, etc.
The major vendors covered:
Bayer
Pfizer
Sanofi
Piramal
Abbott
Galderma
Mission
Alkem
Xiuzheng
Teva
Perrigo
West-Ward
HPGC
Yunnan Baiyao
Starpharma
Novel
Edenvridge
レポート目次1 Bacterial Vaginosis Drug Market Overview
1.1 Bacterial Vaginosis Drug Product Scope
1.2 Bacterial Vaginosis Drug Segment by Type
1.2.1 Global Bacterial Vaginosis Drug Sales by Type (2020-2026)
1.2.2 Rx
1.2.3 OTC
1.3 Bacterial Vaginosis Drug Segment by Application
1.3.1 Global Bacterial Vaginosis Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Bacterial Vaginosis Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Bacterial Vaginosis Drug Sales Growth Rate (2015-2026)
1.4.2 Global Bacterial Vaginosis Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Bacterial Vaginosis Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Bacterial Vaginosis Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Bacterial Vaginosis Drug Industry
1.5.1.1 Bacterial Vaginosis Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Bacterial Vaginosis Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Bacterial Vaginosis Drug Players to Combat Covid-19 Impact
2 Bacterial Vaginosis Drug Estimate and Forecast by Region
2.1 Global Bacterial Vaginosis Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Bacterial Vaginosis Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Bacterial Vaginosis Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Bacterial Vaginosis Drug Revenue Market Share by Region (2015-2020)
2.3 Global Bacterial Vaginosis Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Bacterial Vaginosis Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Bacterial Vaginosis Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Bacterial Vaginosis Drug Estimates and Projections (2015-2026)
2.4.2 Europe Bacterial Vaginosis Drug Estimates and Projections (2015-2026)
2.4.3 China Bacterial Vaginosis Drug Estimates and Projections (2015-2026)
2.4.4 Japan Bacterial Vaginosis Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Bacterial Vaginosis Drug Estimates and Projections (2015-2026)
2.4.6 India Bacterial Vaginosis Drug Estimates and Projections (2015-2026)
3 Global Bacterial Vaginosis Drug Competition Landscape by Players
3.1 Global Top Bacterial Vaginosis Drug Players by Sales (2015-2020)
3.2 Global Top Bacterial Vaginosis Drug Players by Revenue (2015-2020)
3.3 Global Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Drug as of 2019)
3.4 Global Bacterial Vaginosis Drug Average Price by Company (2015-2020)
3.5 Manufacturers Bacterial Vaginosis Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Bacterial Vaginosis Drug Players (Opinion Leaders)
4 Global Bacterial Vaginosis Drug Market Size by Type
4.1 Global Bacterial Vaginosis Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Bacterial Vaginosis Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Bacterial Vaginosis Drug Price by Type (2014-2020)
4.2 Global Bacterial Vaginosis Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Bacterial Vaginosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Bacterial Vaginosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Bacterial Vaginosis Drug Price Forecast by Type (2021-2026)
5 Global Bacterial Vaginosis Drug Market Size by Application
5.1 Global Bacterial Vaginosis Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Bacterial Vaginosis Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Bacterial Vaginosis Drug Price by Application (2015-2020)
5.2 Global Bacterial Vaginosis Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Bacterial Vaginosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Bacterial Vaginosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Bacterial Vaginosis Drug Price Forecast by Application (2021-2026)
3 North America Bacterial Vaginosis Drug Market Facts & Figures
3.2 North America Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
3.3 North America Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
3.4 North America Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
4 Europe Bacterial Vaginosis Drug Market Facts & Figures
4.2 Europe Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
4.3 Europe Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
4.4 Europe Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
5 China Bacterial Vaginosis Drug Market Facts & Figures
5.2 China Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
5.3 China Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
5.4 China Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
6 Japan Bacterial Vaginosis Drug Market Facts & Figures
6.2 Japan Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
6.3 Japan Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
6.4 Japan Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Bacterial Vaginosis Drug Market Facts & Figures
7.2 Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
8 India Bacterial Vaginosis Drug Market Facts & Figures
8.2 India Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
8.3 India Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
8.4 India Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Bacterial Vaginosis Drug Business
12.1 Bayer
12.1.1 Bayer Bacterial Vaginosis Drug Corporation Information
12.1.2 Bayer Bacterial Vaginosis Drug Business Overview and Total Revenue
12.1.3 Bayer Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Bacterial Vaginosis Drug Products Offered
12.1.5 Bayer Recent Development
12.2 Pfizer
12.2.1 Pfizer Bacterial Vaginosis Drug Corporation Information
12.2.2 Pfizer Bacterial Vaginosis Drug Business Overview and Total Revenue
12.2.3 Pfizer Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Bacterial Vaginosis Drug Products Offered
12.2.5 Pfizer Recent Development
12.3 Sanofi
12.3.1 Sanofi Bacterial Vaginosis Drug Corporation Information
12.3.2 Sanofi Bacterial Vaginosis Drug Business Overview and Total Revenue
12.3.3 Sanofi Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Sanofi Bacterial Vaginosis Drug Products Offered
12.3.5 Sanofi Recent Development
12.4 Piramal
12.4.1 Piramal Bacterial Vaginosis Drug Corporation Information
12.4.2 Piramal Bacterial Vaginosis Drug Business Overview and Total Revenue
12.4.3 Piramal Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Piramal Bacterial Vaginosis Drug Products Offered
12.4.5 Piramal Recent Development
12.5 Abbott
12.5.1 Abbott Bacterial Vaginosis Drug Corporation Information
12.5.2 Abbott Bacterial Vaginosis Drug Business Overview and Total Revenue
12.5.3 Abbott Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Abbott Bacterial Vaginosis Drug Products Offered
12.5.5 Abbott Recent Development
12.6 Galderma
12.6.1 Galderma Bacterial Vaginosis Drug Corporation Information
12.6.2 Galderma Bacterial Vaginosis Drug Business Overview and Total Revenue
12.6.3 Galderma Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Galderma Bacterial Vaginosis Drug Products Offered
12.6.5 Galderma Recent Development
12.7 Mission
12.7.1 Mission Bacterial Vaginosis Drug Corporation Information
12.7.2 Mission Bacterial Vaginosis Drug Business Overview and Total Revenue
12.7.3 Mission Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Mission Bacterial Vaginosis Drug Products Offered
12.7.5 Mission Recent Development
12.8 Alkem
12.8.1 Alkem Bacterial Vaginosis Drug Corporation Information
12.8.2 Alkem Bacterial Vaginosis Drug Business Overview and Total Revenue
12.8.3 Alkem Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Alkem Bacterial Vaginosis Drug Products Offered
12.8.5 Alkem Recent Development
12.9 Xiuzheng
12.9.1 Xiuzheng Bacterial Vaginosis Drug Corporation Information
12.9.2 Xiuzheng Bacterial Vaginosis Drug Business Overview and Total Revenue
12.9.3 Xiuzheng Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Xiuzheng Bacterial Vaginosis Drug Products Offered
12.9.5 Xiuzheng Recent Development
12.10 Teva
12.10.1 Teva Bacterial Vaginosis Drug Corporation Information
12.10.2 Teva Bacterial Vaginosis Drug Business Overview and Total Revenue
12.10.3 Teva Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Teva Bacterial Vaginosis Drug Products Offered
12.10.5 Teva Recent Development
12.11 Perrigo
12.11.1 Perrigo Bacterial Vaginosis Drug Corporation Information
12.11.2 Perrigo Bacterial Vaginosis Drug Business Overview and Total Revenue
12.11.3 Perrigo Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Perrigo Bacterial Vaginosis Drug Products Offered
12.11.5 Perrigo Recent Development
12.12 West-Ward
12.12.1 West-Ward Bacterial Vaginosis Drug Corporation Information
12.12.2 West-Ward Bacterial Vaginosis Drug Business Overview and Total Revenue
12.12.3 West-Ward Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 West-Ward Bacterial Vaginosis Drug Products Offered
12.12.5 West-Ward Recent Development
12.13 HPGC
12.13.1 HPGC Bacterial Vaginosis Drug Corporation Information
12.13.2 HPGC Bacterial Vaginosis Drug Business Overview and Total Revenue
12.13.3 HPGC Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.13.4 HPGC Bacterial Vaginosis Drug Products Offered
12.13.5 HPGC Recent Development
12.14 Yunnan Baiyao
12.14.1 Yunnan Baiyao Bacterial Vaginosis Drug Corporation Information
12.14.2 Yunnan Baiyao Bacterial Vaginosis Drug Business Overview and Total Revenue
12.14.3 Yunnan Baiyao Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Yunnan Baiyao Bacterial Vaginosis Drug Products Offered
12.14.5 Yunnan Baiyao Recent Development
12.15 Starpharma
12.15.1 Starpharma Bacterial Vaginosis Drug Corporation Information
12.15.2 Starpharma Bacterial Vaginosis Drug Business Overview and Total Revenue
12.15.3 Starpharma Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Starpharma Bacterial Vaginosis Drug Products Offered
12.15.5 Starpharma Recent Development
12.16 Novel
12.16.1 Novel Bacterial Vaginosis Drug Corporation Information
12.16.2 Novel Bacterial Vaginosis Drug Business Overview and Total Revenue
12.16.3 Novel Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Novel Bacterial Vaginosis Drug Products Offered
12.16.5 Novel Recent Development
12.17 Edenvridge
12.17.1 Edenvridge Bacterial Vaginosis Drug Corporation Information
12.17.2 Edenvridge Bacterial Vaginosis Drug Business Overview and Total Revenue
12.17.3 Edenvridge Bacterial Vaginosis Drug Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Edenvridge Bacterial Vaginosis Drug Products Offered
12.17.5 Edenvridge Recent Development
13 Bacterial Vaginosis Drug Manufacturing Cost Analysis
13.1 Bacterial Vaginosis Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bacterial Vaginosis Drug
13.4 Bacterial Vaginosis Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bacterial Vaginosis Drug Distributors List
14.3 Bacterial Vaginosis Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of TablesTable 1. Global Bacterial Vaginosis Drug Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Bacterial Vaginosis Drug Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Bacterial Vaginosis Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Bacterial Vaginosis Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Bacterial Vaginosis Drug Players to Combat Covid-19 Impact
Table 8. Global Market Bacterial Vaginosis Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Bacterial Vaginosis Drug Sales (K MT) by Region (2015-2020)
Table 10. Global Bacterial Vaginosis Drug Sales Market Share by Region (2015-2020)
Table 11. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Bacterial Vaginosis Drug Revenue Share by Region (2015-2020)
Table 13. Global Bacterial Vaginosis Drug Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Bacterial Vaginosis Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Bacterial Vaginosis Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Bacterial Vaginosis Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Bacterial Vaginosis Drug (K MT) of Key Companies (2015-2020)
Table 18. Global Bacterial Vaginosis Drug Sales Share by Company (2015-2020)
Table 19. Global Bacterial Vaginosis Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Bacterial Vaginosis Drug Revenue Share by Company (2015-2020)
Table 21. Global Bacterial Vaginosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Drug as of 2019)
Table 22. Global Bacterial Vaginosis Drug Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Bacterial Vaginosis Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Bacterial Vaginosis Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Bacterial Vaginosis Drug Players
Table 27. Global Bacterial Vaginosis Drug Sales (K MT) by Type (2015-2020)
Table 28. Global Bacterial Vaginosis Drug Sales Share by Type (2015-2020)
Table 29. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Bacterial Vaginosis Drug Price (K MT) by Type (2015-2020)
Table 31. Global Bacterial Vaginosis Drug Sales Share by Type (2021-2026)
Table 32. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Bacterial Vaginosis Drug Revenue Share by Type (2021-2026)
Table 34. Global Bacterial Vaginosis Drug Price (K MT) by Type (2021-2026)
Table 35. Global Bacterial Vaginosis Drug Sales (K MT) by Application (2015-2020)
Table 36. Global Bacterial Vaginosis Drug Sales Share by Application (2015-2020)
Table 37. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Bacterial Vaginosis Drug Price (K MT) by Application (2015-2020)
Table 39. Global Bacterial Vaginosis Drug Sales (K MT) by Application (2021-2026)
Table 40. Global Bacterial Vaginosis Drug Sales Share by Application (2021-2026)
Table 41. Global Bacterial Vaginosis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Bacterial Vaginosis Drug Revenue Share by Application (2021-2026)
Table 43. Global Bacterial Vaginosis Drug Price (K MT) by Application (2021-2026)
Table 44. United States Bacterial Vaginosis Drug Sales (K MT) by Company (2015-2020)
Table 45. United States Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 46. United States Bacterial Vaginosis Drug Sales (K MT) by Type (2015-2020)
Table 47. United States Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 48. United States Bacterial Vaginosis Drug Sales (K MT) by Application (2015-2020)
Table 49. United States Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Bacterial Vaginosis Drug Sales (K MT) by Company (2015-2020)
Table 51. Europe Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Bacterial Vaginosis Drug Sales (K MT) by Type (2015-2020)
Table 53. Europe Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Bacterial Vaginosis Drug Sales (K MT) by Application (2015-2020)
Table 55. Europe Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 56. China Bacterial Vaginosis Drug Sales (K MT) by Company (2015-2020)
Table 57. China Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 58. China Bacterial Vaginosis Drug Sales (K MT) by Type (2015-2020)
Table 59. China Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 60. China Bacterial Vaginosis Drug Sales (K MT) by Application (2015-2020)
Table 61. China Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Bacterial Vaginosis Drug Sales (K MT) by Company (2015-2020)
Table 63. Japan Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Bacterial Vaginosis Drug Sales (K MT) by Type (2015-2020)
Table 65. Japan Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Bacterial Vaginosis Drug Sales (K MT) by Application (2015-2020)
Table 67. Japan Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Bacterial Vaginosis Drug Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Bacterial Vaginosis Drug Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Bacterial Vaginosis Drug Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 74. India Bacterial Vaginosis Drug Sales (K MT) by Company (2015-2020)
Table 75. India Bacterial Vaginosis Drug Sales Market Share by Company (2015-2020)
Table 76. India Bacterial Vaginosis Drug Sales (K MT) by Type (2015-2020)
Table 77. India Bacterial Vaginosis Drug Sales Market Share by Type (2015-2020)
Table 78. India Bacterial Vaginosis Drug Sales (K MT) by Application (2015-2020)
Table 79. India Bacterial Vaginosis Drug Sales Market Share by Application (2015-2020)
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Bayer Bacterial Vaginosis Drug Product
Table 84. Bayer Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Bacterial Vaginosis Drug Product
Table 89. Pfizer Recent Development
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Sanofi Bacterial Vaginosis Drug Product
Table 94. Sanofi Recent Development
Table 95. Piramal Corporation Information
Table 96. Piramal Description and Business Overview
Table 97. Piramal Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Piramal Bacterial Vaginosis Drug Product
Table 99. Piramal Recent Development
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Abbott Bacterial Vaginosis Drug Product
Table 104. Abbott Recent Development
Table 105. Galderma Corporation Information
Table 106. Galderma Description and Business Overview
Table 107. Galderma Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Galderma Bacterial Vaginosis Drug Product
Table 109. Galderma Recent Development
Table 110. Mission Corporation Information
Table 111. Mission Description and Business Overview
Table 112. Mission Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Mission Bacterial Vaginosis Drug Product
Table 114. Mission Recent Development
Table 115. Alkem Corporation Information
Table 116. Alkem Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Alkem Description and Business Overview
Table 118. Alkem Bacterial Vaginosis Drug Product
Table 119. Alkem Recent Development
Table 120. Xiuzheng Corporation Information
Table 121. Xiuzheng Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Xiuzheng Description and Business Overview
Table 123. Xiuzheng Bacterial Vaginosis Drug Product
Table 124. Xiuzheng Recent Development
Table 125. Teva Corporation Information
Table 126. Teva Description and Business Overview
Table 127. Teva Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Teva Bacterial Vaginosis Drug Product
Table 129. Teva Recent Development
Table 130. Perrigo Corporation Information
Table 131. Perrigo Description and Business Overview
Table 132. Perrigo Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Perrigo Bacterial Vaginosis Drug Product
Table 134. Perrigo Recent Development
Table 135. West-Ward Corporation Information
Table 136. West-Ward Description and Business Overview
Table 137. West-Ward Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. West-Ward Bacterial Vaginosis Drug Product
Table 139. West-Ward Recent Development
Table 140. HPGC Corporation Information
Table 141. HPGC Description and Business Overview
Table 142. HPGC Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. HPGC Bacterial Vaginosis Drug Product
Table 144. HPGC Recent Development
Table 145. Yunnan Baiyao Corporation Information
Table 146. Yunnan Baiyao Description and Business Overview
Table 147. Yunnan Baiyao Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Yunnan Baiyao Bacterial Vaginosis Drug Product
Table 149. Yunnan Baiyao Recent Development
Table 150. Starpharma Corporation Information
Table 151. Starpharma Description and Business Overview
Table 152. Starpharma Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Starpharma Bacterial Vaginosis Drug Product
Table 154. Starpharma Recent Development
Table 155. Novel Corporation Information
Table 156. Novel Description and Business Overview
Table 157. Novel Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Novel Bacterial Vaginosis Drug Product
Table 159. Novel Recent Development
Table . Edenvridge Corporation Information
Table . Edenvridge Description and Business Overview
Table . Edenvridge Bacterial Vaginosis Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . Edenvridge Bacterial Vaginosis Drug Product
Table . Edenvridge Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Bacterial Vaginosis Drug Distributors List
Table 168. Bacterial Vaginosis Drug Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Bacterial Vaginosis Drug Product Picture
Figure 2. Global Bacterial Vaginosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bacterial Vaginosis Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Pharmacy Examples
Figure 8. Other Examples
Figure 9. Global Bacterial Vaginosis Drug Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Bacterial Vaginosis Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Bacterial Vaginosis Drug Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Bacterial Vaginosis Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Bacterial Vaginosis Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Bacterial Vaginosis Drug Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Bacterial Vaginosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Bacterial Vaginosis Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Bacterial Vaginosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Bacterial Vaginosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Bacterial Vaginosis Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Bacterial Vaginosis Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Bacterial Vaginosis Drug Players Market Share by Revenue in Bacterial Vaginosis Drug 2015 & 2019
Figure 27. Bacterial Vaginosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Bacterial Vaginosis Drug Revenue Share by Type (2015-2020)
Figure 29. Global Bacterial Vaginosis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Bacterial Vaginosis Drug Revenue Share by Application (2015-2020)
Figure 31. Global Bacterial Vaginosis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Bacterial Vaginosis Drug Sales Market Share by Type in 2019
Figure 33. United States Bacterial Vaginosis Drug Sales Market Share by Type in 2019
Figure 34. Europe Bacterial Vaginosis Drug Sales Market Share by Company in 2019
Figure 35. Europe Bacterial Vaginosis Drug Sales Market Share by Type in 2019
Figure 36. Europe Bacterial Vaginosis Drug Sales Market Share by Application in 2019
Figure 37. China Bacterial Vaginosis Drug Sales Market Share by Company in 2019
Figure 38. China Bacterial Vaginosis Drug Sales Market Share by Type in 2019
Figure 39. China Bacterial Vaginosis Drug Sales Market Share by Application in 2019
Figure 40. Japan Bacterial Vaginosis Drug Sales Market Share by Company in 2019
Figure 41. Japan Bacterial Vaginosis Drug Sales Market Share by Type in 2019
Figure 42. Japan Bacterial Vaginosis Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Bacterial Vaginosis Drug Sales Market Share by Application in 2019
Figure 46. India Bacterial Vaginosis Drug Sales Market Share by Company in 2019
Figure 47. India Bacterial Vaginosis Drug Sales Market Share by Type in 2019
Figure 48. India Bacterial Vaginosis Drug Sales Market Share by Application in 2019
Figure 49. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Piramal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Galderma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Mission Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Alkem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Xiuzheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. West-Ward Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. HPGC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Yunnan Baiyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Starpharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Novel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Edenvridge Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of Bacterial Vaginosis Drug
Figure 68. Manufacturing Process Analysis of Bacterial Vaginosis Drug
Figure 69. Bacterial Vaginosis Drug Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
細菌性結膜炎の世界市場レポート2020 Conjunctivitis is a communicable disease. It is also known as pink eye in the United States and madras eye in India. Conjunctivitis is an inflammation of conjunctiva. Conjunctivitis caused by bacteria, viruses and allergens.Symptoms of bacterial conjunctivitis are reddening of eyes, excess tears, th…- 微生物および細菌繊維の世界市場レポート2020 Market Analysis and Insights: Global Microbial and Bacterial Fibre Market The global Microbial and Bacterial Fibre market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Microbial and Bacterial Fibre Scope and M…
- 細菌発酵エキスの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Bacterial Fermentation Extract market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bacterial Ferm…
- 細菌ワクチンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bacterial Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bacterial Vaccines market …
- 細菌およびウイルスフィルターの世界市場レポート2020 Bacterial filter is a filter fine enough to prevent the passage of bacteria (0.5–5 μm in diameter), which permits removal of bacteria from solutions. Market Analysis and Insights: Global Bacterial and Viral Filter Market The global Bacterial and Viral Filter market was valued at US$ xx million in 20…